Chemoresistance‑associated Alternative Splicing Signatures in Serous Ovarian Cancer

Oncology Letters - Greece
doi 10.3892/ol.2020.11562
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Clinical Interest of Combining Transcriptomic and Genomic Signatures in High-Grade Serous Ovarian Cancer

Frontiers in Genetics
GeneticsMolecular Medicine
2020English

Notch Signaling in Serous Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2014English

Notch Signaling in Serous Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2014English

Cancer-Associated SF3B1 Mutations Affect Alternative Splicing by Promoting Alternative Branchpoint Usage

European Journal of Cancer
Cancer ResearchOncology
2016English

New in High Grade Serous Ovarian Cancer Treatment

Effective Pharmacotherapy
2019English

Genomic Copy Number Alterations in Serous Ovarian Cancer

2018English

RNA Immune Signatures From Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers

Cancers
Cancer ResearchOncology
2020English

Gene Expression Signatures Differentiate Ovarian/Peritoneal Serous Carcinoma From Breast Carcinoma in Effusions

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2010English

Overexpression of Cathepsin L Is Associated With Chemoresistance and Invasion of Epithelial Ovarian Cancer

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy